サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1450917

血管ステント市場レポート：製品タイプ、材料、送達モード、エンドユーザー、地域別 2024-2032

Vascular Stents Market Report by Product Type, Material, Mode of Delivery, End-User, and Region 2024-2032
出版日: | 発行: IMARC | ページ情報: 英文 141 Pages | 納期: 2～3営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.76円
血管ステント市場レポート：製品タイプ、材料、送達モード、エンドユーザー、地域別 2024-2032
出版日: 2024年03月02日
発行: IMARC
ページ情報: 英文 141 Pages
納期: 2～3営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界の血管ステント市場規模は2023年に106億米ドルに達しました。今後、IMARC Groupは、2032年には171億米ドルに達し、2024～2032年の成長率（CAGR）は5.3％になると予測しています。同市場は、冠動脈や末梢動脈などの心血管系疾患の有病率の増加、高齢化社会への人口動態の変化、血管ステントの性能と安全性を高めるための新素材、設計、コーティングの市場開拓などにより、着実な成長を遂げています。

血管ステント市場の分析：

市場の成長と規模：市場は緩やかな成長を遂げていますが、これは心血管疾患の有病率が増加していることに起因しています。また、個人の間で不健康なライフスタイルを採用する傾向が高まっていることも、市場の成長を後押ししています。

技術の進歩：技術革新は先進的な薬剤溶出ステントの開発につながり、全体的な成果を高めています。さらに、ステント留置術を改善するための低侵襲（MI）技術の採用が市場の成長を支えています。

業界の用途血管ステントは冠動脈、末梢動脈、その他の血管領域に使用されます。このほか、血流の回復や合併症の予防にも不可欠であり、市場にプラスの影響を与えています。

地理的動向：北米はヘルスケアのインフラが確立しており、市場をリードしています。しかし、欧州は高齢化人口の増加に牽引され、急成長市場として浮上しています。

競合情勢：市場の主要プレーヤーは、競争力を維持するためにいくつかの戦略的イニシアティブに積極的に取り組んでいます。医療機関や医師と協力して臨床試験を実施し、ステントの性能に関する実際のデータを収集することで、市場の成長を後押ししています。

課題と機会：市場は、承認やコンプライアンスに関する規制のハードルなどの課題に直面しているが、新興国市場でのステント需要の高まりに対応する機会にも恵まれています。

将来の展望：血管ステント市場の将来は、高齢化社会と相まって、技術的進歩により有望視されています。

血管ステント市場の動向：

心血管疾患の増加

冠動脈疾患や末梢動脈疾患などの心血管疾患の有病率の増加が市場の成長を強めています。これらの疾患は、座りがちなライフスタイル、不健康な食生活、人口の高齢化などが原因で世界的に増加しています。血管ステントは、閉塞または狭窄した動脈の血流を回復させることにより、これらの疾患の治療において重要な役割を果たしています。心血管系疾患に罹患する人が多いため、血管ステントの需要は世界中で高まっています。ヘルスケア提供者と患者が効果的で低侵襲（MI）な解決策を求めるようになり、血管ステントの需要が増加しています。このことは、ステント技術の重要性と、心血管障害の負担が増加している人口のヘルスケアニーズに対応する上で極めて重要な役割を担っていることを強調しています。

高齢化と長寿化

高齢化社会への人口動態の変化が市場の成長を後押ししています。高齢者は、アテローム性動脈硬化症やその他の血管疾患など、加齢に関連した疾患にかかりやすくなっています。血管ステント、特に薬剤溶出性ステントや生体吸収性ステントは、高齢者のこれらの疾患を効果的に管理する上で不可欠なものとなっています。平均寿命の延長とヘルスケアの進歩が相まって、血管に影響を及ぼす慢性疾患の有病率が高くなっています。血管ステントは、高齢患者の血流を改善し合併症のリスクを軽減するための低侵襲（MI）ソリューションを提供します。ヘルスケアシステムは高齢化社会の医療ニーズを満たすために適応しつつあり、血管ステントはこの取り組みにおいて重要な役割を果たしています。

技術の進歩と製品の革新

血管ステントの性能と安全性を高めるために、メーカーは常に新しい材料、デザイン、コーティングを開発しています。さらに、技術の進歩は薬剤溶出ステント（DES）や生体吸収性ステントの開発につながっており、これらのステントは再狭窄を減少させ、長期合併症を最小限に抑えることで患者の予後を改善しています。さらに、ステントデリバリーシステムと低侵襲（MI）手技の革新により、ステント留置がより安全で効率的になりつつあります。これに伴い、研究開発（R&D）活動により、血管疾患に対してより安全で効果的な治療選択肢を提供できる、より強化された血管ステントが生み出されつつあります。さらに、特定の患者のニーズに合わせて調整され、より良い臨床結果に貢献するステントへの需要が高まっていることも、良好な市場見通しをもたらしています。

糖尿病と肥満の蔓延

糖尿病と肥満の有病率の増加が市場の成長を後押ししています。糖尿病と肥満はアテローム性動脈硬化症などの心血管疾患につながるため、治療のために血管ステントの使用が必要になることが多いです。糖尿病はまた、血糖値の上昇やそれに伴う合併症により、冠動脈疾患や末梢動脈疾患の発症にもつながります。同様に、肥満は血管内のプラークの蓄積と関連しており、インターベンションが必要な動脈閉塞の可能性を高めています。さらに、ヘルスケアプロバイダーは、糖尿病や肥満の患者に生じる複雑な血管の問題を管理するためにステントに依存しており、それが市場の成長に寄与しています。

目次

第1章 序文

第2章 調査範囲と調査手法

  • 調査目的
  • 利害関係者
  • データソース
    • 一次情報
    • 二次情報
  • 市場推定
    • ボトムアップアプローチ
    • トップダウンアプローチ
  • 調査手法

第3章 エグゼクティブサマリー

第4章 イントロダクション

  • 概要
  • 主要産業動向

第5章 血管ステントの世界市場

  • 市場概要
  • 市場実績
  • COVID-19の影響
  • 市場内訳：製品タイプ別
  • 市場内訳：材料別
  • 市場内訳：投与形態別
  • 市場内訳：エンドユーザー別
  • 市場内訳：地域別
  • 市場予測

第6章 市場内訳：製品タイプ別

  • 冠動脈ステント
    • 市場動向
    • 市場予測
  • 末梢血管用ステント
    • 市場動向
    • 市場予測
  • EVARステントグラフト
    • 市場動向
    • 市場予測

第7章 市場内訳：材料別

  • 金属ステント
    • 市場動向
    • 市場内訳：タイプ別
      • コバルトクロム
        • 市場動向
        • 市場予測
      • 白金クロム
        • 市場動向
        • 市場予測
      • ニッケルチタン
        • 市場動向
        • 市場予測
      • ステンレス鋼
        • 動向
        • 市場予測
    • 市場予測
  • その他
    • 市場動向
    • 市場予測

第8章 市場内訳：送達様式別

  • バルーン拡張型ステント
    • 市場動向
    • 市場予測
  • 自己拡張型ステント
    • 市場動向
    • 市場予測

第9章 市場内訳：エンドユーザー別

  • 病院、心臓センター
    • 市場動向
    • 市場予測
  • 外来手術センター
    • 市場動向
    • 市場予測

第10章 市場内訳：地域別

  • 北米
    • 市場動向
    • 市場予測
  • 欧州
    • 市場動向
    • 市場予測
  • アジア太平洋
    • 市場動向
    • 市場予測
  • 中東・アフリカ地域
    • 市場動向
    • 市場予測
  • ラテンアメリカ
    • 市場動向
    • 市場予測

第11章 SWOT分析

  • 概要
  • 強み
  • 弱み
  • 機会
  • 脅威

第12章 バリューチェーン分析

第13章 ポーターのファイブフォース分析

  • 概要
  • 買い手の交渉力
  • 供給企業の交渉力
  • 競合の程度
  • 新規参入業者の脅威
  • 代替品の脅威

第14章 価格分析

  • 価格指標
  • 価格構造
  • マージン分析

第15章 競合情勢

  • 市場構造
  • 主要企業
  • 主要企業のプロファイル
    • Medtronic Plc
    • Abbott Laboratories
    • Boston Scientific Corporation
    • Biotronik Se & Co. Kg
    • Braun Melsungen Ag
    • Terumo Corporation
    • Microport Scientific Corporation
    • Meril Life Sciences Pvt. Ltd.
    • Vascular Concepts Limited
    • C.R. Bard, Inc.
    • W.L. Gore and Associates, Inc.
    • Endologix, Inc.
    • Lombard Medical
    • Translumina Gmbh
    • Jotec Gmbh
図表

List of Figures

  • Figure 1: Global: Vascular Stents Market: Major Drivers and Challenges
  • Figure 2: Global: Vascular Stents Market: Sales Value (in Billion US$), 2018-2023
  • Figure 3: Global: Vascular Stents Market: Breakup by Product Type (in %), 2023
  • Figure 4: Global: Vascular Stents Market: Breakup by Material (in %), 2023
  • Figure 5: Global: Vascular Stents Market: Breakup by Mode of Delivery (in %), 2023
  • Figure 6: Global: Vascular Stents Market: Breakup by End-User (in %), 2023
  • Figure 7: Global: Vascular Stents Market: Breakup by Region (in %), 2023
  • Figure 8: Global: Vascular Stents Market Forecast: Sales Value (in Billion US$), 2024-2032
  • Figure 9: Global: Vascular Stents Industry: SWOT Analysis
  • Figure 10: Global: Vascular Stents Industry: Value Chain Analysis
  • Figure 11: Global: Vascular Stents Industry: Porter's Five Forces Analysis
  • Figure 12: Global: Vascular Stents (Coronary Stents) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 13: Global: Vascular Stents (Coronary Stents) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 14: Global: Vascular Stents (Peripheral Vascular Stents) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 15: Global: Vascular Stents (Peripheral Vascular Stents) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 16: Global: Vascular Stents (EVAR Stent Grafts) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 17: Global: Vascular Stents (EVAR Stent Grafts) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 18: Global: Vascular Stents (Metallic Stents) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 19: Global: Vascular Stents (Metallic Stents) Market: Breakup by Type (in %), 2023
  • Figure 20: Global: Vascular Stents (Cobalt Chromium) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 21: Global: Vascular Stents (Cobalt Chromium) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 22: Global: Vascular Stents (Platinum Chromium) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 23: Global: Vascular Stents (Platinum Chromium) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 24: Global: Vascular Stents (Nickel Titanium) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 25: Global: Vascular Stents (Nickel Titanium) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 26: Global: Vascular Stents (Stainless Steel) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 27: Global: Vascular Stents (Stainless Steel) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 28: Global: Vascular Stents (Metallic Stents) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 29: Global: Vascular Stents (Other Material Types) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 30: Global: Vascular Stents (Other Material Types) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 31: Global: Vascular Stents (Balloon-Expandable Stents) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 32: Global: Vascular Stents (Balloon-Expandable Stents) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 33: Global: Vascular Stents (Self-Expanding Stents) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 34: Global: Vascular Stents (Self-Expanding Stents) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 35: Global: Vascular Stents (Hospitals and Cardiac Centers) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 36: Global: Vascular Stents (Hospitals and Cardiac Centers) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 37: Global: Vascular Stents (Ambulatory Surgical Centers) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 38: Global: Vascular Stents (Ambulatory Surgical Centers) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 39: North America: Vascular Stents Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 40: North America: Vascular Stents Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 41: Europe: Vascular Stents Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 42: Europe: Vascular Stents Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 43: Asia Pacific: Vascular Stents Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 44: Asia Pacific: Vascular Stents Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 45: Middle East and Africa: Vascular Stents Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 46: Middle East and Africa: Vascular Stents Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 47: Latin America: Vascular Stents Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 48: Latin America: Vascular Stents Market Forecast: Sales Value (in Million US$), 2024-2032

List of Tables

  • Table 1: Global: Vascular Stents Market: Key Industry Highlights, 2023 and 2032
  • Table 2: Global: Vascular Stents Market Forecast: Breakup by Product Type (in Million US$), 2024-2032
  • Table 3: Global: Vascular Stents Market Forecast: Breakup by Material (in Million US$), 2024-2032
  • Table 4: Global: Vascular Stents Market Forecast: Breakup by Mode of Delivery (in Million US$), 2024-2032
  • Table 5: Global: Vascular Stents Market Forecast: Breakup by End-User (in Million US$), 2024-2032
  • Table 6: Global: Vascular Stents Market Forecast: Breakup by Region (in Million US$), 2024-2032
  • Table 7: Global: Vascular Stents Market Structure
  • Table 8: Global: Vascular Stents Market: Key Players
目次
Product Code: SR112024A1382

The global vascular stents market size reached US$ 10.6 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 17.1 Billion by 2032, exhibiting a growth rate (CAGR) of 5.3% during 2024-2032. The market is experiencing steady growth driven by the increasing prevalence of cardiovascular diseases, such as coronary artery and peripheral artery, demographic shift towards an aging population, and development of new materials, designs, and coatings to enhance the performance and safety of vascular stents.

Vascular Stents Market Analysis:

Market Growth and Size: The market is witnessing moderate growth, which can be attributed to the increasing prevalence of cardiovascular diseases. In addition, the rising adoption of unhealthy lifestyles among individuals is propelling the growth of the market.

Technological Advancements: Innovations are leading to the development of advanced drug-eluting stents, which is enhancing the overall outcome. Moreover, the adoption of minimally invasive (MI) techniques to improve the stenting procedure is supporting the growth of the market.

Industry Applications: Vascular stents are used in coronary arteries, peripheral arteries, and other vascular areas. Besides this, they are vital in restoring blood flow and preventing complications, which is positively influencing the market.

Geographical Trends: North America leads the market on account of its well-established healthcare infrastructure. However, Europe is emerging as a fast-growing market, driven by the growing aging population.

Competitive Landscape: Key players in the market are actively engaged in several strategic initiatives to maintain their competitive edge. They are collaborating with healthcare institutions and physicians to conduct clinical trials and gather real-world data on stent performance, which is impelling the market growth.

Challenges and Opportunities: While the market faces challenges, such as regulatory hurdles for market players in terms of approvals and compliance, it also encounters opportunities in catering to the growing demand for stents in developing regions.

Future Outlook: The future of the vascular stents market looks promising, with technological advancements, coupled with an aging population.

Vascular Stents Market Trends:

Rising incidences of cardiovascular diseases

The increasing prevalence of cardiovascular diseases, such as coronary artery disease and peripheral artery disease, is strengthening the growth of the market. These conditions are rising worldwide due to sedentary lifestyles, unhealthy diets, and an aging population. Vascular stents play a crucial role in the treatment of these diseases by restoring blood flow to blocked or narrowed arteries. With numerous people affected by cardiovascular ailments, the demand for vascular stents is growing around the world. As healthcare providers and patients are seeking effective and minimally invasive (MI) solutions, there is a rise in the demand for vascular stents. This factor underscores the importance of stent technologies and their pivotal role in addressing the healthcare needs of a population with an increasing burden of cardiovascular disorders.

Aging population and increased longevity

The demographic shift towards an aging population is propelling the growth of the market. Elderly people are more susceptible to age-related conditions, including atherosclerosis and other vascular diseases. Vascular stents, especially drug-eluting and bioabsorbable varieties, are becoming vital in managing these conditions effectively in older adults. Longer life expectancy, coupled with advancements in healthcare, is leading to a higher prevalence of chronic diseases that affect blood vessels. Vascular stents offer a minimally invasive (MI) solution for improving blood flow and reducing the risk of complications in elderly patients. Healthcare systems are adapting to meet the healthcare needs of aging populations, and vascular stents play a crucial role in this effort.

Technological advancements and product innovations

Manufacturers are consistently developing new materials, designs, and coatings to enhance the performance and safety of vascular stents. In addition, technological advancements are leading to the development of drug-eluting stents (DES) and bioabsorbable stents, which offer improved patient outcomes by reducing restenosis and minimizing long-term complications. Additionally, innovations in stent delivery systems and minimally invasive (MI) procedures are making stent placement safer and more efficient. In line with this, research and development (R&D) activities are resulting in enhanced vascular stents that can provide safer and more effective treatment options for vascular diseases. Moreover, the growing demand for stents that are tailored as per specific patient needs, contributing to better clinical outcomes is offering a favorable market outlook.

Prevalence of diabetes and obesity

The increasing prevalence of diabetes and obesity is bolstering the growth of the market. Diabetes and obesity lead to cardiovascular diseases, including atherosclerosis, which often necessitates the use of vascular stents for treatment. Diabetes can also lead to the development of coronary artery disease and peripheral artery disease due to elevated blood sugar levels and associated complications. Similarly, obesity is linked to the accumulation of plaque in blood vessels, increasing the likelihood of arterial blockages that require intervention. Moreover, healthcare providers rely on stents to manage the complex vascular issues arising in individuals with diabetes and obesity, thereby contributing to the growth of the market.

Vascular Stents Industry Segmentation:

IMARC Group provides an analysis of the key trends in each segment of the market, along with forecasts at the global and regional levels for 2024-2032. Our report has categorized the market based on product type, material, mode of delivery, and end-user.

Breakup by Product Type:

Coronary Stents

Peripheral Vascular Stents

EVAR Stent Grafts

Coronary stents account for the majority of the market share

The report has provided a detailed breakup and analysis of the market based on the product type. This includes coronary stents, peripheral vascular stents, and EVAR stent grafts. According to the report, coronary stents represent the largest segment as these stents are specifically designed to treat blockages and narrowing in the coronary arteries, which supply blood to the heart muscle. They are crucial in the management of coronary artery disease, a leading cause of cardiovascular morbidity and mortality worldwide. Advancements in coronary stent technologies, including drug-eluting stents, are improving patient outcomes, which is impelling the market growth.

Peripheral vascular stents are designed to treat blockages and stenosis in arteries outside the heart, typically in the lower extremities, neck, and renal arteries. This segment addresses the needs of patients suffering from peripheral artery disease (PAD), a condition that affects blood flow in the limbs and organs. Minimally invasive (MI) procedures involving peripheral stents are gaining traction, providing a less invasive option for patients.

EVAR stent grafts are specialized devices used to treat aortic aneurysms. These stent grafts are deployed within the aorta to reinforce the weakened vessel wall, reducing the risk of aneurysm rupture. They also offer a less invasive alternative to open surgical procedures for managing aortic aneurysms, leading to quicker patient recovery and lower post-operative complications.

Breakup by Material:

Metallic Stents

Cobalt Chromium

Platinum Chromium

Nickel Titanium

Stainless Steel

Others

Metallic stents hold the largest share in the industry

A detailed breakup and analysis of the market based on the material have also been provided in the report. This includes metallic stents (cobalt chromium, platinum chromium, nickel titanium, and stainless steel) and others. According to the report, metallic stents account for the largest market share as these stents are primarily made from materials like stainless steel, cobalt-chromium, and nitinol, known for their durability and biocompatibility. They can be further classified into bare-metal stents (BMS) and drug-eluting stents (DES), wherein bare-metal stents are uncoated and provide structural support to keep arteries open, while drug-eluting stents are coated with medications that are slowly released to prevent restenosis or the re-narrowing of the treated artery. In addition, metallic stents are used in the treatment of coronary artery disease and peripheral artery disease, offering reliability and efficacy.

Breakup by Mode of Delivery:

Balloon-Expandable Stents

Self-Expanding Stents

Balloon-expandable stents represent the leading market segment

The report has provided a detailed breakup and analysis of the market based on the mode of delivery. This includes balloon-expandable stents and self-expanding stents. According to the report, balloon-expandable stents represent the largest segment.

Balloon-expandable stents are designed to be implanted using an angioplasty balloon catheter. When the stent is in the desired position within the artery, the balloon is inflated, causing the stent to expand and press against the arterial wall, keeping the vessel open. Balloon-expandable stents are widely used in coronary interventions and are preferred in situations where precise placement and control over stent deployment are critical. Their ability to provide accurate sizing and positioning within the vessel, contributing to successful procedures and improved patient outcomes.

Self-expanding stents are designed to expand automatically when deployed. They are typically made from materials with shape memory properties, such as nitinol, which allows them to self-expand and conform to the shape of the vessel. This segment of the market is particularly suitable for use in peripheral arteries and anatomical locations where precise placement can be challenging with balloon-expandable stents. Self-expanding stents are also favored for treating vessels with varying diameters or tortuous anatomy.

Breakup by End-User:

Hospitals and Cardiac Centers

Ambulatory Surgical Centers

Hospitals and cardiac centers exhibit a clear dominance in the market

The report has provided a detailed breakup and analysis of the market based on the end-user. This includes hospitals and cardiac centers and ambulatory surgical centers. According to the report, hospitals and cardiac centers represent the largest segment.

Hospitals and cardiac centers serve as the primary hubs for complex cardiovascular procedures and interventions, including the implantation of vascular stents. The comprehensive infrastructure and specialized cardiac teams in hospitals make them well-equipped to handle a wide range of cases, ranging from emergency cardiac procedures to elective stent placements. Additionally, hospitals often have access to the latest technologies and equipment required for stent implantation and follow-up care, which further strengthens their position as the dominant end-users of vascular stents.

Ambulatory surgical centers (ASCs) are a growing segment in the market. These facilities offer outpatient surgical procedures, including vascular stent placements, in a more streamlined and convenient setting compared to traditional hospitals. ASCs are gaining traction due to their ability to provide cost-effective and patient-centered care. They are particularly suitable for less complex cases and elective procedures, allowing patients to undergo stent implantation and return home on the same day.

Breakup by Region:

North America

Europe

Asia Pacific

Middle East and Africa

Latin America

North America leads the market, accounting for the largest vascular stents market share

The market research report has also provided a comprehensive analysis of all the major regional markets, which include North America, Europe, Asia Pacific, the Middle East and Africa, and Latin America. According to the report, North America accounts for the largest market share as the region benefits from a well-established healthcare infrastructure, high medical expenditure, and the increasing prevalence of cardiovascular diseases. The United States plays a pivotal role in driving the market growth, with a substantial patient population and extensive research and development (R&D) activities in the field of vascular stents. The presence of key market players and a focus on technological advancements are contributing to the growth of the market in the region.

Europe is another prominent region in the market, characterized by advanced healthcare systems and a growing aging population. Countries like Germany, France, and the United Kingdom are at the forefront of stent adoption. European regulations ensure rigorous product approvals and safety standards, fostering trust in stent technologies. Besides this, increasing preferences for minimally invasive (MI) treatment options is propelling the market growth across the region.

Asia Pacific represents a region with significant growth potential in the market. The increasing incidence of cardiovascular diseases in countries like India and China, coupled with expanding healthcare access, is catalyzing the demand for vascular stents. Moreover, advancements in healthcare infrastructure and rising awareness of minimally invasive (MI) procedures are strengthening the market growth in this region.

The Middle East and Africa exhibit a growing demand for vascular stents due to changing lifestyles and improvements in healthcare infrastructure. While the market in this region is relatively nascent, it is poised for development as healthcare systems are evolving and the need for vascular stent interventions is becoming more pronounced.

Latin America is another emerging market due to the growing healthcare investments and presence of both multinational and regional stent manufacturers, contributing to the market growth. As healthcare access is improving and awareness about vascular stent treatments is increasing, there is a rise in the demand for vascular stents in the region.

Leading Key Players in the Vascular Stents Industry:

Key players in the market are actively engaged in several strategic initiatives to maintain their competitive edge. They are investing in research and development (R&D) activities to introduce innovative stent technologies, including drug-eluting stents with advanced coatings to minimize restenosis rates and bioabsorbable stents that dissolve over time. Additionally, companies are expanding their geographical presence by entering emerging markets in Asia-Pacific and Latin America, where the demand for vascular stents is rising. Collaboration with healthcare institutions and physicians to conduct clinical trials and gather real-world data on stent performance is also increasing, aiming to demonstrate the effectiveness of their products. Overall, key players are committed to advancing vascular stent technology, expanding their market reach, and ensuring patient outcomes are improving.

The market research report has provided a comprehensive analysis of the competitive landscape. Detailed profiles of all major companies have also been provided. Some of the key players in the market include:

Medtronic Plc

Abbott Laboratories

Boston Scientific Corporation

Biotronik Se & Co. Kg

Braun Melsungen Ag

Terumo Corporation

Microport Scientific Corporation

Meril Life Sciences Pvt. Ltd.

Vascular Concepts Limited

C.R. Bard, Inc.

W.L. Gore and Associates, Inc.

Endologix, Inc.

Lombard Medical

Translumina Gmbh

Jotec Gmbh

(Please note that this is only a partial list of the key players, and the complete list is provided in the report.)

Latest News:

May 13, 2022: Medtronic Plc, a global leader in healthcare technology, announced that it has received U.S. Food and Drug Administration (FDA) approval for the Onyx Frontier(TM) drug-eluting stent (DES). As the latest evolution in the Resolute DES family, Onyx Frontier DES leverages the best-in-class stent platform, with an enhanced delivery system designed to improve deliverability and increase acute performance in even the most challenging of cases.

October 6, 2021: Boston Scientific Corporation announced positive data for the Eluvia(TM) Drug-Eluting Vascular Stent System (Eluvia stent) during a late-breaking clinical trial presentation at the Vascular InterVentional Advances (VIVA) meeting in Las Vegas. This data demonstrated superiority of the Eluvia stent compared to self-expanding bare metal stents (BMS) for the treatment of patients with peripheral artery disease (PAD) and superficial femoral artery (SFA) or popliteal artery (PPA) lesions up to 210 mm in length.

December 17, 2020: MicroPort NeuroTech Co., Ltd., a subsidiary of MicroPort Scientific Corporation, developed the Bridge(R) Vertebral Drug-Eluting Stent, which received a registration certificate issued by China's National Medical Products Administration (NMPA) for the treatment of symptomatic vertebral artery stenosis.

Key Questions Answered in This Report:

  • How has the global vascular stents market performed so far, and how will it perform in the coming years?
  • What are the drivers, restraints, and opportunities in the global vascular stents market?
  • What is the impact of each driver, restraint, and opportunity on the global vascular stents market?
  • What are the key regional markets?
  • What is the breakup of the market based on the product type?
  • Which is the most attractive product type in the vascular stents market?
  • What is the breakup of the market based on the material?
  • Which is the most attractive material in the vascular stents market?
  • What is the breakup of the market based on the mode of delivery?
  • Which is the most attractive mode of delivery in the vascular stents market?
  • What is the breakup of the market based on the end-user?
  • Which is the most attractive end-user in the vascular stents market?
  • What is the competitive structure of the market?
  • Who are the key players/companies in the global vascular stents market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Vascular Stents Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Breakup by Product Type
  • 5.5 Market Breakup by Material
  • 5.6 Market Breakup by Mode of Delivery
  • 5.7 Market Breakup by End-User
  • 5.8 Market Breakup by Region
  • 5.9 Market Forecast

6 Market Breakup by Product Type

  • 6.1 Coronary Stents
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Peripheral Vascular Stents
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast
  • 6.3 EVAR Stent Grafts
    • 6.3.1 Market Trends
    • 6.3.2 Market Forecast

7 Market Breakup by Material

  • 7.1 Metallic Stents
    • 7.1.1 Market Trends
    • 7.1.2 Market Breakup by Type
      • 7.1.2.1 Cobalt Chromium
        • 7.1.2.1.1 Market Trends
        • 7.1.2.1.2 Market Forecast
      • 7.1.2.2 Platinum Chromium
        • 7.1.2.2.1 Market Trends
        • 7.1.2.2.2 Market Forecast
      • 7.1.2.3 Nickel Titanium
        • 7.1.2.3.1 Market Trends
        • 7.1.2.3.2 Market Forecast
      • 7.1.2.4 Stainless Steel
        • 7.1.2.4.1 Market Trends
        • 7.1.2.4.2 Market Forecast
    • 7.1.3 Market Forecast
  • 7.2 Others
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast

8 Market Breakup by Mode of Delivery

  • 8.1 Balloon-Expandable Stents
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Self-Expanding Stents
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast

9 Market Breakup by End-User

  • 9.1 Hospitals and Cardiac Centers
    • 9.1.1 Market Trends
    • 9.1.2 Market Forecast
  • 9.2 Ambulatory Surgical Centers
    • 9.2.1 Market Trends
    • 9.2.2 Market Forecast

10 Market Breakup by Region

  • 10.1 North America
    • 10.1.1 Market Trends
    • 10.1.2 Market Forecast
  • 10.2 Europe
    • 10.2.1 Market Trends
    • 10.2.2 Market Forecast
  • 10.3 Asia Pacific
    • 10.3.1 Market Trends
    • 10.3.2 Market Forecast
  • 10.4 Middle East and Africa
    • 10.4.1 Market Trends
    • 10.4.2 Market Forecast
  • 10.5 Latin America
    • 10.5.1 Market Trends
    • 10.5.2 Market Forecast

11 SWOT Analysis

  • 11.1 Overview
  • 11.2 Strengths
  • 11.3 Weaknesses
  • 11.4 Opportunities
  • 11.5 Threats

12 Value Chain Analysis

13 Porters Five Forces Analysis

  • 13.1 Overview
  • 13.2 Bargaining Power of Buyers
  • 13.3 Bargaining Power of Suppliers
  • 13.4 Degree of Competition
  • 13.5 Threat of New Entrants
  • 13.6 Threat of Substitutes

14 Price Analysis

  • 14.1 Price Indicators
  • 14.2 Price Structure
  • 14.3 Margin Analysis

15 Competitive Landscape

  • 15.1 Market Structure
  • 15.2 Key Players
  • 15.3 Profiles of Key Players
    • 15.3.1 Medtronic Plc
    • 15.3.2 Abbott Laboratories
    • 15.3.3 Boston Scientific Corporation
    • 15.3.4 Biotronik Se & Co. Kg
    • 15.3.5 Braun Melsungen Ag
    • 15.3.6 Terumo Corporation
    • 15.3.7 Microport Scientific Corporation
    • 15.3.8 Meril Life Sciences Pvt. Ltd.
    • 15.3.9 Vascular Concepts Limited
    • 15.3.10 C.R. Bard, Inc.
    • 15.3.11 W.L. Gore and Associates, Inc.
    • 15.3.12 Endologix, Inc.
    • 15.3.13 Lombard Medical
    • 15.3.14 Translumina Gmbh
    • 15.3.15 Jotec Gmbh